Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis

Arthritis Care and Research

Volumn 62, Issue 6, 2010, Pages 873-880

  Faurschou, Mikkel ^a   Dreyer, Lene ^a   Kamper, Anne Lise ^a   Starklint, Henrik ^b   Jacobsen, Søren ^a  

^a Rigshospitalet   (Denmark)

^b LILLEBAELT HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DENMARK; DISEASE COURSE; FEMALE; FOCAL SEGMENTAL NEPHRITIS; FOLLOW UP; HUMAN; KIDNEY BIOPSY; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHRITIS; OUTCOME ASSESSMENT; RISK FACTOR; SCLEROSING NEPHRITIS; STANDARDIZED MORTALITY RATIO; SURVIVAL; SYSTOLIC BLOOD PRESSURE; WORLD HEALTH ORGANIZATION;

ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY; LUPUS NEPHRITIS; MALE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77953096945     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20116     Document Type: Article

References (32)

1. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003;82:299-308. (Pubitemid 37229465)
2. Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM, et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol 1998;17:468-77.
3. Cameron JS. Lupus nephritis. J Am Soc Nephrol 1999;10:413-424
4. Houssiau FA, Ginzler EM. Current treatment of lupus nephritis. Lupus 2008;17:426-430
5. Bono L, Cameron JS, Hicks JA. The very long-term prognosis and complications of lupus nephritis and its treatment. QJM 1999;92:211-218 (Pubitemid 29184885)
6. Donadio JV Jr, Hart GM, Bergstralh EJ, Holley KE. Prognostic determinants in lupus nephritis: a long-term clinicopathologic study. Lupus 1995;4:109-115
7. Moroni G, Quaglini S, Gallelli B, Banfi G, Messa P, Ponticelli C. The long-term outcome of 93 patients with proliferative lupus nephritis. Nephrol Dial Transplant 2007;22:2531-2539 (Pubitemid 47365517)
8. Mok CC, Wong RW, Lau CS. Lupus nephritis in Southern Chinese patients: clinicopathologic findings and long-term outcome. Am J Kidney Dis 1999;34:315-323
9. Esdaile JM, Abrahamowicz M, MacKenzie T, Hayslett JP, Kashgarian M. The time-dependence of long-term prediction in lupus nephritis. Arthritis Rheum 1994;37:359-368 (Pubitemid 24093627)
10. Mok C, Ying K, Yim C, Ng W, Wong W. Very long-term outcome of pure lupus membranous nephropathy treated with glucocorticoid and azathioprine. Lupus 2009;18:1091-1095
11. Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM, et al. Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus. Scand J Rheumatol 1999;28:75-80. (Pubitemid 29173250)
12. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25: 1271-1277 (Pubitemid 13221242)
13. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension- European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21: 1011-1053
14. Juel K, Helweg-Larsen K. The Danish registers of causes of death. Dan Med Bull 1999;46:354-357
15. Hommel K, Rasmussen S, Madsen M, Kamper AL. The Danish Registry on regular dialysis and transplantation: completeness and validity of incident patient registration. Nephrol Dial Transplant 2009. E-pub ahead of print.
16. Churg J, Sobin LH. Renal disease: classification and atlas of glomerular disease. Tokyo: Igaku-Shoin; 1982. p. 127-131
17. Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, et al. Prognostic factors in lupus nephritis: contribution of renal histologic data. Am J Med 1983;75:382-391
18. Esdaile JM, Levinton C, Federgreen W, Hayslett JP, Kashgarian M. The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature. Q J Med 1989;72:779-833. (Pubitemid 19230673)
19. Austin HA 3rd, Boumpas DT, Vaughan EM, Balow JE. Highrisk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients. Nephrol Dial Transplant 1995;10:1620-1628
20. Contreras G, Pardo V, Cely C, Borja E, Hurtado A, De La Cuesta C, et al. Factors associated with poor outcomes in patients with lupus nephritis. Lupus 2005;14:890-895 (Pubitemid 41736370)
21. Huong DL, Papo T, Beaufils H, Wechsler B, Bletry O, Baumelou A, et al. Renal involvement in systemic lupus erythematosus: a study of 180 patients from a single center. Medicine (Baltimore) 1999;78:148-166 (Pubitemid 29231142)
22. Martins L, Rocha G, Rodrigues A, Santos J, Vasconcelos C, Correia J, et al. Lupus nephritis: a retrospective review of 78 cases from a single center. Clin Nephrol 2002;57:114-119 (Pubitemid 34145194)
23. Italian Lupus Nephritis Study Group (GISNEL). Lupus nephritis: prognostic factors and probability of maintaining life-supporting renal function 10 years after the diagnosis. Am J Kidney Dis 1992;19:473-479
24. Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD, and the Lupus Nephritis Collaborative Study Group. Factors predictive of outcome in severe lupus nephritis. Am J Kidney Dis 2000;35:904-914
25. Najafi CC, Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J. Significance of histologic patterns of glomerular in- jury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 2001;59:2156-2163 (Pubitemid 32467607)
26. Faurschou M, Starklint H, Halberg P, Jacobsen S. Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure. J Rheumatol 2006; 33:1563-1569 (Pubitemid 44168828)
27. Austin HA 3rd, Boumpas DT, Vaughan EM, Balow JE. Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int 1994;45:544-550
28. Conlon PJ, Fischer CA, Levesque MC, Smith SR, St Clair EW, Allen NB, et al. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis. Clin Nephrol 1996;46:170-175
29. Derksen RH, Hene RJ, Kater L. The long-term clinical outcome of 56 patients with biopsy-proven lupus nephritis followed at a single center. Lupus 1992;1:97-103.
30. Neumann K, Wallace DJ, Azen C, Nessim S, Fichman M, Metzger AL, et al. Lupus in the 1980s. III. Influence of clinical variables, biopsy, and treatment on the outcome in 150 patients with lupus nephritis seen at a single center. Semin Arthritis Rheum 1995;25:47-55.
31. Esdaile JM, Joseph L, MacKenzie T, Kashgarian M, Hayslett JP. The benefit of early treatment with immunosuppressive agents in lupus nephritis. J Rheumatol 1994;21:2046-2051 (Pubitemid 24352349)
32. Fiehn C, Hajjar Y, Mueller K, Waldherr R, Ho AD, Andrassy K. Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment. Ann Rheum Dis 2003;62:435-439 (Pubitemid 36469735)